Wells Fargo Upgrades Globus Medical to Overweight, Raises Price Target to $78
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo has upgraded Globus Medical (NYSE:GMED) from Equal-Weight to Overweight and raised the price target from $60 to $78.
August 07, 2024 | 12:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo has upgraded Globus Medical from Equal-Weight to Overweight and increased the price target from $60 to $78.
The upgrade from Equal-Weight to Overweight and the significant increase in the price target from $60 to $78 by a reputable analyst at Wells Fargo is likely to positively impact the stock price of Globus Medical in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100